18 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2026.
Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Ascendis Pharma, Inc.'s own public LCA filings (FY2024–FY2026) — the same records an investigator pulls first.
Next end date: 2026-12-14. Employing an H-1B worker past the LCA end date without a new certified LCA is a strict-liability violation — the replacement LCA must be certified before the I-129 extension is filed.
Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.
Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.
No additional recruitment or non-displacement attestations apply.
Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.
Yes — Ascendis Pharma, Inc. sponsors H-1B workers, with 18 certified LCAs on file (FY2021–FY2026), including 1 in FY2026. The median certified salary is $197,500 (P25 $152,000, P75 $245,000). With a 67% transfer share, this employer actively accepts H-1B transfers. 100% of its certified filings meet or exceed the prevailing wage.
Ascendis Pharma, Inc. H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2026).
Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.
The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.
Levels I–IV are DOL prevailing-wage experience tiers; 89% of filings are senior-level (III–IV).
| Fiscal year | Certified | Denied | Withdrawn | Total |
|---|---|---|---|---|
| FY2021 | 6 | 0 | 0 | 6 |
| FY2022 | 4 | 0 | 0 | 4 |
| FY2023 | 6 | 0 | 0 | 6 |
| FY2024 | 1 | 0 | 0 | 1 |
| FY2026 | 1 | 0 | 0 | 1 |
Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.
| Job title | Salary | Level | Location | Filed | Status |
|---|---|---|---|---|---|
Sr. Specialist, IT Business Analysis I-200-25354-499840 | $175,141/yr | III | Palo Alto, CA | Dec 19, 2025 | Certified |
Associate Director, Global PV Operations I-200-24194-193289 | $216,320/yr | IV | Palo Alto, CA | Jul 12, 2024 | Certified |
Head, Global PV Operations I-200-23230-277670 | $275,600/yr | IV | Palo Alto, CA | Aug 18, 2023 | Certified |
Associate Director, Medical Safety Science I-200-23137-029987 | $220,000/yr | IV | Palo Alto, CA | May 17, 2023 | Certified |
Scientist, Formulation Development I-200-23117-969974 | $135,000/yr | II | Redwood City, CA | Apr 26, 2023 | Certified |
Associate Director, Medical Safety Science I-200-23047-779962 | $230,000/yr | IV | Dublin, CA | Feb 16, 2023 | Certified |
Director, Global PV Operations I-200-23045-771831 | $255,000/yr | IV | Benicia, CA | Feb 14, 2023 | Certified |
IT Business Analyst I-200-23020-716120 | $150,000/yr | III | Palo Alto, CA | Jan 20, 2023 | Certified |
Associate Scientist, Analytical Development I-200-22251-460575 | $125,000/yr | II | Redwood City, CA | Sep 08, 2022 | Certified |
IT System Manager I-200-22144-203525 | $158,000/yr | IV | Palo Alto, CA | May 24, 2022 | Certified |
Associate Scientist, Analytical Development I-200-22102-061005 | $125,000/yr | III | Redwood City, CA | Apr 12, 2022 | Certified |
Associate Director, Global PV Operations I-200-21305-679318 | $200,000/yr | III | Princeton, NJ | Nov 01, 2021 | Certified |
Associate Scientist, Analytical Development I-200-21103-220029 | $115,000/yr | III | Redwood City, CA | Apr 13, 2021 | Certified |
Senior Manager, Biostatistics I-200-21050-089776 | $195,000/yr | III | Arlington, MA | Feb 19, 2021 | Certified |
Director, Pharmacovigilance Safety Evaluation I-200-20337-934440 | $250,000/yr | IV | San Jose, CA | Dec 02, 2020 | Certified |
One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.
Worker positions by LCA filing purpose, summed across FY2021–FY2026 disclosure records.
Most active filing months: Feb and Dec — useful for timing transfer conversations.
Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.
3 states · 8 cities
The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:
Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.
Get my private gap check →